CL2017001790A1 - Método para tratar diarrea en animales de compañía - Google Patents

Método para tratar diarrea en animales de compañía

Info

Publication number
CL2017001790A1
CL2017001790A1 CL2017001790A CL2017001790A CL2017001790A1 CL 2017001790 A1 CL2017001790 A1 CL 2017001790A1 CL 2017001790 A CL2017001790 A CL 2017001790A CL 2017001790 A CL2017001790 A CL 2017001790A CL 2017001790 A1 CL2017001790 A1 CL 2017001790A1
Authority
CL
Chile
Prior art keywords
diarrhea
pets
treating diarrhea
proantocianidine
enthermic
Prior art date
Application number
CL2017001790A
Other languages
English (en)
Inventor
Serge Martinod
Original Assignee
Jaguar Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaguar Health Inc filed Critical Jaguar Health Inc
Publication of CL2017001790A1 publication Critical patent/CL2017001790A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>SE PROPORCIONAN MÉTODOS Y COMPOSICIONES PARA TRATAR LA DIARREA, PARTICULARMENTE LA DIARREA SECRETORA, LA DIARREA ACUOSA Y LA DIARREA INDUCIDA CON QUIMIOTERAPIA (CID), EN ANIMALES DE COMPAÑÍA NO HUMANOS JÓVENES Y ADULTOS, TALES COMO PERROS Y GATOS, CON UNA CANTIDAD TERAPÉUTICAMENTE EFICAZ DE UN POLÍMERO DE PROANTOCIANIDINAS DEL CROTON LECHLERI, YA SEA EN FORMA ENTÉRICA O NO ENTÉRICA.</p>
CL2017001790A 2015-01-09 2017-07-07 Método para tratar diarrea en animales de compañía CL2017001790A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562101663P 2015-01-09 2015-01-09
US201562117927P 2015-02-18 2015-02-18

Publications (1)

Publication Number Publication Date
CL2017001790A1 true CL2017001790A1 (es) 2018-04-06

Family

ID=56356484

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001790A CL2017001790A1 (es) 2015-01-09 2017-07-07 Método para tratar diarrea en animales de compañía

Country Status (13)

Country Link
US (1) US20180264061A1 (es)
EP (1) EP3242557A4 (es)
JP (1) JP2018509382A (es)
KR (1) KR20170103834A (es)
CN (1) CN107106536A (es)
AU (1) AU2016205145A1 (es)
BR (1) BR112017014750A2 (es)
CA (1) CA2972996A1 (es)
CL (1) CL2017001790A1 (es)
CO (1) CO2017007823A2 (es)
MX (1) MX2017009011A (es)
RU (1) RU2017127686A (es)
WO (1) WO2016112312A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
CA3086826A1 (en) * 2017-12-27 2019-07-04 Suntory Holdings Limited Composition for improving intestinal barrier function
BR112022025741A2 (pt) * 2020-06-19 2023-01-03 Napo Pharmaceuticals Inc Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)
KR102618266B1 (ko) 2023-09-08 2023-12-27 주식회사 모이스텐 반려동물 복용 편의를 고려한 생분해성 필름 및 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269078C (en) * 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
EP1921076A1 (en) * 2002-10-11 2008-05-14 Proteotech Inc. systhesis of procyanidin B2
EP2061327B1 (en) * 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions for treating or preventing inflammatory bowel disease
JP5684474B2 (ja) * 2006-09-11 2015-03-11 オセラ セラピューティクス， インコーポレイテッド 胃腸の運動障害疾患の治療のためのモチリン受容体の大環状アンタゴニスト
US8709515B1 (en) * 2009-02-19 2014-04-29 Carmen C. H. Colitz Nutritional supplement method
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN102138930A (zh) * 2011-01-04 2011-08-03 海南美兰史克制药有限公司 复方雷贝拉唑钠药物组合物固体制剂
WO2013093655A1 (en) * 2011-12-22 2013-06-27 Glenmark Pharmaceuticals Limited Non-enteric pharmaceutical composition comprising crofelemer
WO2015184111A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating salmonella-induced diarrhea in non-human animals
WO2015184109A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in adult non-human animals
WO2015184101A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in neonatal and young non-human animals

Also Published As

Publication number Publication date
AU2016205145A1 (en) 2017-07-13
CN107106536A (zh) 2017-08-29
JP2018509382A (ja) 2018-04-05
US20180264061A1 (en) 2018-09-20
CO2017007823A2 (es) 2018-01-05
CA2972996A1 (en) 2016-07-14
WO2016112312A1 (en) 2016-07-14
RU2017127686A (ru) 2019-02-11
BR112017014750A2 (pt) 2018-06-19
EP3242557A1 (en) 2017-11-15
MX2017009011A (es) 2017-10-02
KR20170103834A (ko) 2017-09-13
EP3242557A4 (en) 2018-09-05

Similar Documents

Publication Publication Date Title
BR112017006664A2 (pt) terapias de combinação
CL2017002567A1 (es) Composiciones para modular la expresión de c9orf72
AU362319S (en) Pet treat
HK1222635A1 (zh) 浮湖及處理浮湖中水的方法
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
TW201614072A (en) CAR-T lymphocytes engineered to home to lymph node B cell zone, skin, or gastrointestinal tract
MX2020010194A (es) Agente reductor de amoniaco para usarse en el tratamiento de enfermedades asociadas con activacion de celulas estrelladas hepaticas.
EA201591674A1 (ru) Противораковые вакцины и способы лечения с их применением
CL2017001790A1 (es) Método para tratar diarrea en animales de compañía
BR112017005598A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
MX2015015031A (es) Metodos y composiciones de cemento que utilizan fibras de poliolefina tratadas.
MX2017006015A (es) Composiciones para usar en el tratamiento de cancer renal.
GB2533024A (en) Device and system for treatment of fish
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
CO2017008129A2 (es) Método para prevenir o tratar la pérdida de la audición
DK3460052T3 (da) Forbedrede allogene dendrittiske celler til anvendelse i behandling af cancer
EA201890439A1 (ru) ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА)
DK3498000T3 (da) MRS-konfiguration i to niveauer
BR112017012134A2 (pt) prevenção e tratamento de condições inflamatórias
MX2017004657A (es) Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion.
BR112015023260A2 (pt) método de tratamento de grão com ozônio
DK3535530T3 (da) Varmtvands- og energilagring
IL262951A (en) Methods of drug therapy associated with ilc3 cells
FI20155991A (fi) Elektrodimoduuli, sähkökemiallinenreaktori, ja vedenkäsittelylaite
DK3612034T3 (da) Fremgangsmåde til fremstilling af zinkoxid til alimentære anvendelser i svin, andre monogastiske dyr, heste eller drøvtyggere